- Tytuł:
- Safety and efficacy of avalglucosidase alfa versus alglucosidase alfa in patients with late-onset Pompe disease (COMET): a phase 3, randomised, multicentre trial
- Autorzy:
- Źródło:
- In The Lancet Neurology December 2021 20(12):1012-1026
Czasopismo naukowe